NAD+

Overview

NAD⁺ participates in cellular metabolism as an electron carrier, cycling between its oxidized form (NAD⁺) and reduced form (NADH) in redox reactions central to glycolysis, the tricarboxylic acid (TCA) cycle, and mitochondrial oxidative phosphorylation. Its role as an electron acceptor in these pathways makes it an essential component of cellular energy production across nearly all cell types. The NAD⁺/NADH ratio serves as an indicator of cellular redox state and has been examined as a parameter in metabolic and mitochondrial biology research.

Beyond its function as an electron carrier, NAD⁺ serves as a required substrate for several classes of NAD⁺-consuming enzymes. These include sirtuins (NAD⁺-dependent protein deacetylases involved in gene expression and metabolic regulation), poly(ADP-ribose) polymerases (PARPs, which mediate DNA damage response), and CD38 (an NAD⁺-glycohydrolase involved in calcium signaling). Research examining NAD⁺ availability has investigated its relationship to these enzyme systems in preclinical models. Studies on NAD⁺ precursors such as NMN and NR address upstream biosynthesis and do not constitute direct evidence about exogenous NAD⁺ administration; only studies directly testing NAD⁺ itself are relevant to this page.

Chemical Profile

Preclinical Research Findings

Cellular Energy Metabolism and Mitochondrial Research

NAD⁺ has been studied in preclinical models for its role in mitochondrial function and cellular energy metabolism. Research has examined the NAD⁺/NADH ratio as a parameter reflecting the redox state of cells and its relationship to mitochondrial respiratory chain activity. Preclinical models have investigated how changes in intracellular NAD⁺ availability affect mitochondrial membrane potential, ATP synthesis, and metabolic flux through glycolysis and the TCA cycle. These investigations have been conducted across cell types with high metabolic demands, including cardiac, neural, and skeletal muscle tissue models.

Sirtuin Signaling and Gene Expression Research

Sirtuins (SIRT1 through SIRT7) are a class of NAD⁺-dependent protein deacetylases that require NAD⁺ as a co-substrate for their enzymatic activity. Research has examined NAD⁺ availability in preclinical models for its effects on sirtuin-mediated pathways, including SIRT1-regulated gene expression in metabolic tissues, SIRT3 activity in mitochondrial protein deacetylation, and SIRT5 involvement in metabolic enzyme regulation. Studies have investigated how changes in NAD⁺ levels influence sirtuin activity in the context of metabolic signaling and cellular stress responses in experimental models.

DNA Damage Response and PARP Research

Poly(ADP-ribose) polymerases (PARPs), particularly PARP1 and PARP2, are NAD⁺-consuming enzymes that play a central role in the cellular response to DNA strand breaks. Research has examined NAD⁺ availability in the context of PARP-mediated DNA damage signaling and base excision repair in preclinical models. Studies have investigated the relationship between intracellular NAD⁺ levels and PARP activity in models of genotoxic stress, with observations reported on DNA repair capacity and cell survival parameters in experimental settings. This area of research has been studied primarily in vitro and in preclinical tissue models.

Areas of Preclinical Research

• Cellular energy metabolism and NAD⁺/NADH redox biology studies
• Mitochondrial function and oxidative phosphorylation research
• Sirtuin signaling and NAD⁺-dependent gene expression studies
• PARP activity and DNA damage response research
• Metabolic tissue modeling and cellular redox state research

Research Use Only: This product is sold exclusively for laboratory and scientific research. It is not approved for human or veterinary use or consumption.

Disclaimer: All products distributed by Resolve Peptides are supplied exclusively for controlled laboratory and scientific research. They are not drugs, supplements, or therapies, and have not been approved by the FDA or any regulatory authority for human or veterinary use. These products are not intended for human or veterinary administration. Regulatory status of research peptides is subject to change; it is the responsibility of the researcher to verify current applicable regulations in their jurisdiction prior to purchase. Any references to biological effects are based solely on experimental and preclinical data.